|
Market Closed -
Bombay S.E.
06:02:26 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 2,551.05 INR | -1.86% |
|
-3.52% | +81.05% |
| 08-11 | NGL Fine-Chem Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 05-25 | NGL Fine-Chem Limited, 2026 Earnings Call, May 25, 2026 |
| Market Cap | 15.76B 166M 149M 137M 124M 232M 236M 1.63B 655M 8.29B 623M 610M 26.15B | P/E 2025 |
32.6x | P/E 2026 | 26.6x |
|---|---|---|---|---|---|
| Enterprise Value | 16.54B 174M 156M 144M 130M 243M 248M 1.71B 687M 8.7B 654M 640M 27.44B | EV / Sales 2025 |
1.9x | EV / Sales 2026 | 2.71x |
| Free-Float |
27.51% | Yield 2025 |
0.16% | Yield 2026 | 0.08% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| NGLFINE | Delayed | |
NSE India S.E.
| NGLFINE | Delayed |
Last Transcript: NGL Fine-Chem Limited
| 1 day | -1.86% | ||
| 1 week | -3.52% | ||
| 1 month | -12.29% | ||
| 3 months | -21.87% | ||
| 6 months | +13.65% | ||
| Current year | +81.05% |
| 1 week | 2,550 | 2,702.95 | |
| 1 month | 2,467.6 | 3,251 | |
| Current year | 1,322 | 3,595 | |
| 1 year | 1,261 | 3,595 | |
| 3 years | 962.7 | 3,595 | |
| 5 years | 962.7 | 3,595 | |
| 10 years | 220 | 3,789.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 2015-06-29 | |
| Director of Finance/CFO | 50 | 2009-08-27 | |
Shivam Gharat
CMP | Compliance Officer | - | 2026-02-02 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 2011-08-11 | |
| Director/Board Member | 50 | 2010-07-20 | |
Jayaram Sitaram
BRD | Director/Board Member | - | 2015-08-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.86% | -3.52% | +69.72% | +41.51% | 166M | ||
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | ||
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | ||
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | ||
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | ||
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | ||
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | ||
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | ||
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | ||
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | ||
| Average | +1.69% | +4.96% | +48.90% | +80.26% | 426.21B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.43% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.68B 38.78M 34.73M 31.95M 28.95M 54.11M 55.13M 381M 153M 1.94B 146M 142M 6.11B | 5.01B 52.76M 47.25M 43.46M 39.38M 73.61M 74.99M 518M 208M 2.64B 198M 194M 8.31B |
| Net income | 211M 2.22M 1.99M 1.83M 1.66M 3.1M 3.16M 21.86M 8.77M 111M 8.35M 8.17M 350M | 481M 5.07M 4.54M 4.18M 3.78M 7.07M 7.2M 49.79M 19.99M 253M 19.02M 18.62M 798M |
| Net Debt | 116M 1.22M 1.09M 1M 910K 1.7M 1.73M 11.97M 4.81M 60.86M 4.57M 4.48M 192M | 783M 8.24M 7.38M 6.79M 6.15M 11.5M 11.72M 81M 32.51M 412M 30.94M 30.28M 1.3B |
Employees
498
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | ₹2,551.05 | -1.86% | 100 |
| 26-10-29 | ₹2,599.50 | -1.01% | 149 |
| 26-10-28 | ₹2,625.95 | +0.04% | 102 |
| 26-10-27 | ₹2,625.00 | +0.21% | 17 |
| 26-10-26 | ₹2,619.45 | -0.94% | 320 |
- Stock Market
- Stocks
- NGLFINE Stock
Select your edition
All financial news and data tailored to specific country editions

















